Inflammation Flashcards
Pro inflammatory cytokines
TNF, IL1 IL6, most Chemokines (CCL2 CCL3)
Anti inflammatory cytokines
IL4, IL10, IL13, TGF-B
Antiviral cytokines
IFN-a, IFN-b
B-cell activating cytokines
IL4, IL5, IL6, IL21
T-cell activating cytokines
IFN-y, IL2, IL4, IL12
Macrophages activating cytokines
IFN-y
Eosinophil and mast cell activating cytokines
IL3, IL4, IL5, IL13
Order of leukocyte infiltration in response to inflammation
Neutrophil spike (pro-inflammatory cytokines released), Macrophage spike (anti-inflammatory cytokines relased), lymphocytes come in (adaptive T cells/B cells too), and then resolution
Plasma vs serum
Plasma has clotting factors as well, Serum lacks clotting factors. None have RBC or WBC
Lymphocyte characteristics
Large circular nucleus, little else
Monocyte characteristics
dumb-bell-shaped nucleus, little else
Macrophages
Derived from monocytes and larger cells
Neutrophils
Large granules and polarized
Eosinophils
Crystallized granules staining with eosin in H&E stain
Basophils
Dense granules staining cytoplasmic blue in H&E stain
Symptoms of inflammation
redness, swelling, heat, pain, LOF
Steps of WBCs entering site of inflammation
1) tethering/rolling. Selectins bind to epithelial cells. 2) integrin activation. Endothelial cells have vesicles filled with chemokines/cytokines and release them, which activates integrin on WBCs. Integrins slow roll drastically. 3) Stable adhesion, integrins anchor WBC and they search for ways to pass endothelial to enter basement membrane. 4) Diapedesis. Can either be paracellular (between) or transcellular (through)
IL1 interacts with receptor, what happens?
IL1R is a type1 cytokine receptor that activates NF-kB and MAPK
IL1 antagonist
IL1ra. drug analog: Anakinra
IL6, IL2, IL3 interacts with receptor, what happens?
Type 1 Tyrosine Kinase receptor and activates JAK-STAT signaling. 1) receptor dimerization. 2) Dimerization activates JAK phosphorylation of cytokine receptor. 3) Recruits STATs phosphrylated by JAK. 4) Phosphorylated STATs dimerize and translocate to nucleus to activate genes
JAK-STAT inhibitors
Ruxolitinib, Tofacitinib. Both treat rheumatoid arthritis and psoriasis
TNFa interacts with receptor, what happens?
TNFa interacts with TNFa-R induces both gene transcription AND apoptosis, depending on downstream complexes because the TNFa-R has a “death domain” that allows for TRADD to bind (leads to apoptosis) or TRAF (gene transcription)
Clinical actions of TNFa
low levels: local inflammation, leukocyte activation, endothelial activation
moderate levels: systemic inflammation - fever, liver inflammation, leukocyte proliferation
high levels: septic shock
Negative regulators of TNFa
AU-Rich elements in the 3’UTR of oncogenes (including TNFa) allows destruction of TNFa. KO of ARE have chronic inflammation